Immuneering Corporation Total Liabilities and Equity
Immuneering Corporation (IMRX) had Total Liabilities and Equity of $202.06 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet
us-gaap:LiabilitiesAndStockholdersEquity · last filed 2026-08-05
- 2026-06-30: Liabilities and Equity $202.06M.
- 2026-03-31: Liabilities and Equity $214.81M.
- 2025-12-31: Liabilities and Equity $231.99M.
- 2025-09-30: Liabilities and Equity $241.06M.
| Period end | Liabilities and Equity |
|---|---|
| 2026-06-30 | $202.06M 10-Q · filed 2026-08-05 |
| 2026-03-31 | $214.81M 10-Q · filed 2026-05-15 |
| 2025-12-31 | $231.99M 10-Q · filed 2026-08-05 |
| 2025-09-30 | $241.06M 10-Q · filed 2025-11-12 |
| 2025-06-30 | $40.06M 10-Q · filed 2025-08-13 |
| 2025-03-31 | $50.68M 10-Q · filed 2025-05-05 |
| 2024-12-31 | $52.71M 10-K · filed 2026-03-06 |
| 2024-09-30 | $68.56M 10-Q · filed 2024-11-13 |
| 2024-06-30 | $77.09M 10-Q · filed 2024-08-06 |
| 2024-03-31 | $87.98M 10-Q · filed 2024-05-07 |
| 2023-12-31 | $102.58M 10-K · filed 2025-03-20 |
| 2023-09-30 | $113.88M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $124.90M 10-Q · filed 2023-08-03 |
| 2023-03-31 | $107.70M 10-Q · filed 2023-05-04 |
| 2022-12-31 | $122.37M 10-K · filed 2024-03-01 |
| 2022-09-30 | $133.69M 10-Q · filed 2022-11-10 |
| 2022-06-30 | $142.05M 10-Q · filed 2022-08-10 |
| 2022-03-31 | $152.45M 10-Q · filed 2022-05-10 |
| 2021-12-31 | $166.70M 10-K · filed 2023-03-06 |
| 2021-09-30 | $164.04M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $53.04M 10-Q · filed 2021-09-09 |
| 2020-12-31 | $38.42M 10-K · filed 2022-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |